• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Marginal Zone Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.边缘区淋巴瘤：沙特淋巴瘤组诊断、管理及随访临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):202-208. doi: 10.4103/sjmms.sjmms_97_19. Epub 2019 Aug 28.
2
Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up of Patients with Various Types of Lymphoma during the Coronavirus Disease 2019 Pandemic.沙特淋巴瘤小组关于2019冠状病毒病大流行期间各类淋巴瘤患者诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2020 Sep-Dec;8(3):227-238. doi: 10.4103/sjmms.sjmms_457_20. Epub 2020 Aug 20.
3
Follicular Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.滤泡性淋巴瘤：沙特淋巴瘤小组关于诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):214-218. doi: 10.4103/sjmms.sjmms_101_19. Epub 2019 Aug 28.
4
Hodgkin's Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.霍奇金淋巴瘤：沙特淋巴瘤小组关于诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):195-201. doi: 10.4103/sjmms.sjmms_96_19. Epub 2019 Aug 28.
5
Mantle Cell Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.套细胞淋巴瘤：沙特淋巴瘤小组关于诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):226-230. doi: 10.4103/sjmms.sjmms_105_19. Epub 2019 Aug 28.
6
Diffuse Large B-Cell Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.弥漫性大B细胞淋巴瘤：沙特淋巴瘤小组关于诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):209-213. doi: 10.4103/sjmms.sjmms_98_19. Epub 2019 Aug 28.
7
Primary Central Nervous System Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.原发性中枢神经系统淋巴瘤：沙特淋巴瘤小组关于诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):219-221. doi: 10.4103/sjmms.sjmms_103_19. Epub 2019 Aug 28.
8
Natural Killer/T-Cell Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.自然杀伤细胞/ T细胞淋巴瘤：沙特淋巴瘤小组关于诊断、管理和随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):222-225. doi: 10.4103/sjmms.sjmms_104_19. Epub 2019 Aug 28.
9
Primary Mediastinal Large B-Cell Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.原发性纵隔大B细胞淋巴瘤：沙特淋巴瘤小组关于诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):231-233. doi: 10.4103/sjmms.sjmms_106_19. Epub 2019 Aug 28.
10
Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.边缘区淋巴瘤：ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2020 Jan;31(1):17-29. doi: 10.1016/j.annonc.2019.10.010. Epub 2019 Dec 4.

引用本文的文献

1
Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up of Patients with Various Types of Lymphoma during the Coronavirus Disease 2019 Pandemic.沙特淋巴瘤小组关于2019冠状病毒病大流行期间各类淋巴瘤患者诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2020 Sep-Dec;8(3):227-238. doi: 10.4103/sjmms.sjmms_457_20. Epub 2020 Aug 20.

本文引用的文献

1
Results of Upfront Therapy for Marginal Zone Lymphoma.边缘区淋巴瘤的初始治疗结果
Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):879-883. doi: 10.1016/j.clml.2017.09.014. Epub 2017 Sep 23.
2
Investigation of three potential autoantibodies in Sjogren's syndrome and associated MALT lymphoma.干燥综合征及相关黏膜相关淋巴组织淋巴瘤中三种潜在自身抗体的研究。
Oncotarget. 2017 May 2;8(18):30039-30049. doi: 10.18632/oncotarget.15613.
3
Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.IELSG-19 随机试验的最终结果：利妥昔单抗联合苯丁酸氮芥与苯丁酸氮芥或利妥昔单抗单药治疗黏膜相关淋巴组织淋巴瘤的无事件和无进展生存得到改善。
J Clin Oncol. 2017 Jun 10;35(17):1905-1912. doi: 10.1200/JCO.2016.70.6994. Epub 2017 Mar 29.
4
Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma.在复发/难治性边缘区淋巴瘤中使用依鲁替尼靶向布鲁顿酪氨酸激酶。
Blood. 2017 Apr 20;129(16):2224-2232. doi: 10.1182/blood-2016-10-747345. Epub 2017 Feb 6.
5
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.美国胃肠病学会临床指南：幽门螺杆菌感染的治疗
Am J Gastroenterol. 2017 Feb;112(2):212-239. doi: 10.1038/ajg.2016.563. Epub 2017 Jan 10.
6
Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial.奥滨尤妥珠单抗联合苯达莫司汀对比苯达莫司汀单药治疗利妥昔单抗难治性惰性非霍奇金淋巴瘤（GADOLIN）：一项随机、对照、开放标签、多中心、3 期临床试验。
Lancet Oncol. 2016 Aug;17(8):1081-1093. doi: 10.1016/S1470-2045(16)30097-3. Epub 2016 Jun 23.
7
Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402.利妥昔单抗延长给药方案或再治疗方案用于低肿瘤负荷非滤泡性惰性B细胞非霍奇金淋巴瘤：东部肿瘤协作组E4402方案
Br J Haematol. 2016 Jun;173(6):867-75. doi: 10.1111/bjh.14007. Epub 2016 Mar 11.
8
Histologic transformation in marginal zone lymphomas†.边缘区淋巴瘤中的组织学转化。
Ann Oncol. 2015 Nov;26(11):2329-35. doi: 10.1093/annonc/mdv368. Epub 2015 Sep 23.
9
Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study.比较奥滨尤妥珠单抗（GA101）与利妥昔单抗治疗复发的CD20+惰性B细胞非霍奇金淋巴瘤患者的随机II期试验：GAUSS研究的最终分析
J Clin Oncol. 2015 Oct 20;33(30):3467-74. doi: 10.1200/JCO.2014.59.2139. Epub 2015 Aug 17.
10
Modern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group.原发性皮肤淋巴瘤的现代放射治疗：国际淋巴瘤放射肿瘤学组的照射野及剂量指南
Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):32-9. doi: 10.1016/j.ijrobp.2015.01.008.

Marginal Zone Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.

作者信息

Kandil Magdy, Alhashmi Hani, Alzahrani Musa, Alhejazi Ayman, Motabi Ibraheem, Dada Reyad, Al-Mansour Mubarak, Sagheir Ahmed

机构信息

Oncology Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.

Clinical Oncology Department, Cairo University, Giza, Egypt.

出版信息

Saudi J Med Med Sci. 2019 Sep-Dec;7(3):202-208. doi: 10.4103/sjmms.sjmms_97_19. Epub 2019 Aug 28.

DOI:10.4103/sjmms.sjmms_97_19
PMID:31543745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6734739/
Abstract
摘要